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Abstract
Background: Impact of illness may vary with the medication adherence which in turn may vary with the attitude towards drugs. There is a paucity of research 
examining relationships between these variables. Objective: To study the levels of drug attitude, adherence and its relationship with the impact of illness. Methods: 
A total of 279 participants with mental illness in remission were assessed with socio-demographic and clinical proforma, scales like Hogan Drug Attitude Inven-
tory (DAI), Impact of Illness Scale (IIS), and Morisky Medication Adherence Scale (MMAS) were used. Results: Mean score on DAI, IIS, and MMAS were 2.38 
(SD = 4.6), 25.88 (SD = 6.6), and 5.04 (SD = 2.2) respectively. On linear regression analysis (R2 = .122, DF = 2, F = 17.598, p < .001) IIS Score was statistically 
significant but negatively associated with the score of MMAS (p < .05) and DAI (p < .05). Discussion: Impact of illness has an inverse relationship with the level 
of drug attitude and medication adherence. Improving drug attitude and adherence may buffer the impact of illness.
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Introduction
Mental illnesses often have direct or indirect consequences, leading 
to distress and disability that undermine the quality of life1. Impact 
of mental illness includes feeling restricted, disrupted personal and 
family routine, problems in personal, emotional & social adjustment, 
financial strain, feeling overwhelmed and burdened2. It is determined 
by severity of the symptoms, duration of the episodes, forms of 
the symptoms, treatment response, coping skills, stress load, co-
morbidity, and lifestyle. However, it remains unclear as to which 
factors best predict the quality of life3. Being a leading cause of DALY, 
and a neglected area of concern by the government like in India, and 
with a strong recommendation from World Health Organization for 
further research, it is important to explore the impact of mental illness 
among Indian population. To the best of our knowledge, no studies 
have explored the impact of mental illness in Indian population 
using standardised assessment tools. Mental illness results in adverse 
consequences1, hence there is a need to know the level of the impact 
of mental illness.
Exploring the patient’s attitude towards medication is important 
as it helps to better understand the patients. Attitude of patients 
toward medication depends on multiple factors like overall 
perception of medications as good or bad, effect and side effects of 
the medication, and willingness to opt for medication4. More positive 
attitude towards medication and adherence has been associated with 
better insight (in the presence of a mental disorder) and sharing a 
good relationship with the treating physician. Predictors of positive 
attitude towards medication in mental illness includes insight into 
the need for treatment, a higher attribution of the symptoms to a 
disorder, experience of less negative side effects, presence of biological 
causal beliefs, and less endorsement of psychological causal beliefs5. 
A positive attitude towards medication has a positive correlation 
with adherence6,7. So far, no study has examined drug attitude among 
Indian population using standardised rating scale. 
The WHO defines adherence in long-term therapy as “the 
extent to which a person’s behaviour taking medication, following a 
diet, and/or executing lifestyle changes – corresponds with agreed 
recommendations from a health care provider”8 WHO also reported 
that only 50% of patients with chronic diseases adhere to treatment 
recommendations in developed countries and further quoted 
that “increasing the effectiveness of adherence interventions may 
have a far greater impact on the health of the population than any 
improvement in specific medical treatments”8. Attitude towards 
medication may directly or indirectly mediate the impact of illness. 
A negative attitude, delay or refusal of treatment may lead to higher 
impact of illness. Indirect evidence suggests that better attitude 
towards medication may alleviate the impact of illness9. 
Keeping in view that mental illness is not only associated with 
adverse consequences which vary with the levels of adherence, 
but drug attitude may also influence the adherence, hence it may 
indirectly determine the impact of illness. There is a knowledge gap 
as to what are the levels and relationships of these variables. As per 
our knowledge, no study has examined the relationship between these 
variables which further warrants a need to examine these variables.
With the above background, this study was conducted to know 
the drug attitude andmedication adherence and their relationship 
with impact of illness, among those with mental illnesses. We 
hypothesized that impact of illness has an inverse relation with level 
of drug attitude and adherence.
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Methods
The study was hospital based cross sectional study and was conducted 
at the Outpatient Department of Psychiatry, JSS medical college, 
Mysore, India. The subjects were recruited from March 2018 till 
September 2018. Two hundred and seventy nine participants, who 
were living in the community after an episode of mental illness and 
attended outpatient department of psychiatry during follow-up, 
were recruited after obtaining an informed consent. Patients who 
were between age of 18-65 years of age, with at least one episode of 
mental illness in the past but currently in remission (as ascertained 
by the treating psychiatrist through a detailed clinical examination) 
were included in the study. Those who had chronic physical illness 
or disability (as it may influence the perception of impact of mental 
illness) were excluded from the study. Participants with psychiatric 
diagnosis of Mental Retardation and Dementia were also excluded 
due to reliability issue. Participants who met the selection criteria 
underwent further assessment with the following tools: 
1) Socio-demographic and clinical Proforma – which included 
age, gender, marital status, education, religion, occupation, 
domicile status, socio-economic status, medication preferen-
ce, use of self-medication and diagnosis.
2) Drug Attitude Inventory (DAI) – To assess the attitude to-
wards medication, DAI was used after translating it to Kan-
nada language. This tool was initially developed in 19832. This 
self-administered tool has 30 items with true/false response 
options. Each correct answer is rewarded with 1 point while 
for a wrong answer, 1 point is deducted. It has good internal 
consistency (α = 0.88), test-retest reliability (r = 0.99, p < 10) 
and inter-rater reliability (ICC = 0.99)4.
3) Impact of Illness Scale (IIS) – This scale was developed by 
Klimidis et al. in 2001, to assess impact of illness10. The IIS is 
a short, easy to administer scale, and has a high internal con-
sistency coefficient alpha of 0.93. It has been used in diverse 
socio-cultural settings to measure the illness impact. The scale 
assesses areas of relationship, work, joy & recreation, social & 
religious obligation, family obligation, routine chores, daily 
needs, mobility, and participation. Studies suggest that IIS is 
a reliable and gives valid measure of psychosocial impact of 
illness that may be applicable in a wide range of socio-cultural 
settings10. In our study this scale too was administered after 
translation to Kannada.
4) Morisky Medication Adherence Scale- This is a self-reporting 
scale and has 8 items with yes/no response options. Correct 
response is given 1 point, while incorrect response is scored 
0. Score of < 6 indicates low adherence, score of 6-8 indi-
cates medium adherence, and a score of ≥ 8 indicates high 
adherence. This scale has a sensitivity and specificity of 93% 
and 53% respectively, and Cronbach’s alpha value of 0.8311. 
A translated Kannada version was used in this study.
The data was analyzed using SPSS version 21. Descriptive 
statistics were used to analyze demographic and clinical features. 
Exploratory analysis was done to the find out the relationships 
between DAI, MMAS and IIS score with socio-demographic and 
clinical variables, while linear regression analysis was done to know 
the relationship of score on DAI and MMAS with the score on IIS. 
Results
In this study, the majority of subjects were educated, married, 
unemployed, from a rural background, Hindus, from low 
socioeconomic status, had preferences for modern treatment, had 
a history of self-medication in the past, and had a past episode of 
mood disorder (Table 1).
Mean age of participants was 38.42 (SD = 12.6) years. Mean 
score on DAI, IIS, and MMAS were 2.38 (SD = 4.6), 25.88 (SD = 
6.6), and 5.04 (SD = 2.2) correspondingly (Table 2). On the score 
of DAI, no statistically significant group difference was observed 
among socio-demographic variables except for domicile status (MU 
Table 1. Socio-demographic and clinical characteristics
Variables n %
Gender
Male 144 49.8
Female 145 50.2
Occupation
Employed 128 44.3
Unemployed 161 55.7
Education
Uneducated 34 11.8
Primary 57 19.7
Up to PUC 173 59.9
Graduate 25 8.7
Residence
Rural 204 70.6
Urban 85 29.4
Religion
Hindu 267 92.4
Muslim 19 6.6
Christian 3 1.0
Socio-economic status
Low 201 69.6
Middle 83 28.7
High 5 1.7
Marital status
Single 69 23.9
Married 220 76.1
Medication preference
Allopathic 272 94.1
Ayurvedic 17 5.9
Self-medication
Never 84 29.1
Some time 171 59.2
Frequently 34 11.8
Diagnosis
F 10 52 18.0
F20 14 4.8
F30 187 64.7
F40 36 12.5
Table 2. Socio-demographic and clinical characteristics
Variables Minimum Maximum Mean Std. deviation
Age 15 73 38.26 12.48
DAI Score -10.00 10.00 2.38 4.46
IIS Score .00 36.00 25.88 6.59
MMAS Score .00 7.00 5.04 2.23
= 5571.50, Z = -1.86, p < .05) and education (χ2 = 6.771, DF = 2, p 
< .05) (Tables 3 and 4).
Similarly on the IIS score, no statistically significant group 
difference was observed among socio-demographic variables except 
occupation (MU = 6.88, Z = -2.02, p < .05) and diagnosis (χ2 = 8.92, 
DF = 2, p < .05) (Table 3 and 4).
On the score of MMAS, statistically significant group difference 
was observed for demographic variables – Gender (MU = 7104.50, 
Z = -2.23, p < .05), Medication Preference (MU = 1302.00, Z = 
-1.98, p = < .05), and Self-Medication (χ2 = 17.36, DF = 2, p < .001) 
(Tables 3 and 4).
On linear regression analysis (R2 = .122, DF = 2, F = 17.59, p < 
.001) IIS Score was statistically significant but negatively associated 
with the score of MMAS (p < .05) and DAI (p < .05) (Table 5).
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Table 4. Level of group difference of socio-demographic variables on DAI, IIS Score and MMAS Score
Variables N Mean Rank df p
Education* DAI Score
Primary 34 131.91 2 .034
Up to PUC 57 110.06
Up to graduate 173 96.00
Diagnosis* IIS Score
F10 52 122.02 3 .030
F20 14 156.62
F30 187 134.92
F40 36 97.44
Self-medication* MMAS Score
Never 84 143.77 2 .001
Some time 171 132.85
Frequently 34 83.68
Table 5. Relationships of drug attitude and medication adherence with impact of illness
Model
Unstandardized coefficients Standardized coefficients 95% confidence interval for B t Sig.
B Std. Error Beta Lower bound Upper bound
1 (Constant) 10.200 .408 28.205 33.022 24.986 .001
DAI Score -.082 .034 -.171 -.436 -.037 -2.424 .016
MMAS Score -.218 .069 -.223 -1.062 -.248 -3.157 .002
R2: .122; df: 2, F: 17.598; p: .001; Dependent Variable: IIS Score; Predictors: MMAS Score, DAI Score.
Table 3. Level of group difference of socio-demographic variables on DAI, IIS and MMAS Score
Variables N Mean Rank M U Z p
Residence* DAI Score
Rural 204 135.18 5571.50 -1.864 .050
Urban 85  115.75
Occupation *IIS Score
Employed 128 139.83 6.88 -2.029 .042
Un-employed 161 121.02
Gender *MMAS Score
Male 144 119.94 7104.50 -2.239 .025
Female 145 18437.50
Discussion
The demographic and clinical characteristics were similar to the 
previous studies conducted at the same centre12. The study centre is a 
charitable trust catering services to both rural and urban population 
who are mostly Hindu by religion, and under privileged. In our 
study, we observed a positive attitude towards drugs (mean of 2.38 
out of maximum score of 10). The study centre offers evidence based 
modern treatment that is supposed to be effective. Consistent to our 
previous reports, in this study also, the majority of the participants 
(94%) preferred modern treatment, compared to other methods 
such as Ayurvedic medications. This could also be partially due to 
the higher prevalence of medical model of illness among participants 
attending study centre.
High mean score on 25.88 (maximum possible score 27) indicates 
a high impact of illness on the participants. Mental illness is known 
to affect interpersonal relationships, working capacity, leisure and 
recreational activity, familial obligation etc. Mental illness is also 
known to affect the quality of life of the affected.
Consistent with previous reports, we observed low levels of 
medication adherence. Medication adherence is usually poor in 
subjects with mental illness and many etiological factors play a role 
such as patient related factors, medication related factors and illness 
related factors.
Similar to our findings, other reports revealed varying levels 
of drug attitude, depending upon occupation in patients with 
schizophrenia13. Employed status makes people to have a rational 
view about medication in order to be fit for occupation and free 
from illness. Those who were employed were more likely to have 
higher levels of education than those without employment. Similarly 
those with mood, anxiety and other non-psychotic disorders may 
had a favourable attitude towards medication than those with 
psychotic illness. Research has revealed a disparity between men 
and women in their medication adherence, as observed in this study; 
that may require more personalized drug selection and therapeutic 
management to improve the outcome of an illness14.
Most participants had a preference for modern, mainstream 
treatment. This was congruent with the fact that modern medication 
offers evidence based remedy to the patients; hence better adherence 
was observed in comparison to those that preferred other methods 
such as Ayurvedic. There are reports that concordance depends on 
the patient, illness and clinician factors and patient choice is the 
final common pathway that may be operative in a modern treatment 
method15.
We observed a better adherence of medication with lower level 
of self-medication. Such observation has been made among non-
psychiatric populations with less severe illnesses16. The commonest 
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cause of self-medication is usually symptomatic improvement and 
is often the main reason for poor compliance16.
Consistent with our hypothesis, we observed an inverse 
relationship between IIS score with DAI & MMAS score. Lower 
positive drug attitude is associated with higher impact of illness, 
has been reported earlier17. Observed inverse relationship in this 
study did not appear to be mediated through compliance and 
illness remedial behaviour. Negative drug attitude is known to be a 
predictor of poor compliance and may aggravate the persistence of 
symptoms, negative effect of illness and psychosocial dysfunction 
such as social isolation, loss of employment, and loss of role and 
status. The pharmacophobic (those with a negative drug attitude) are 
often introverted and more likely to be sensitive and relatively less 
judgmental as compared to the pharmacophilic18. On the other hand, 
a positive drug attitude favours greater shared decision making and 
self-efficacy that are helpful in reducing impact of illness19.
With the findings of this study, it can be concluded that negative 
attitude towards medication, low medication adherence and high 
level of impact of illness presents in mental illness in remission. 
Impact of illness has an inverse relationship with level of drug attitude 
and medication adherence. Improving drug attitude and adherence 
may buffer the impact of illness. The findings of this study should be 
interpreted with caution, as it was constrained by its cross sectional 
study design, lack of control group, lack of assessment of insight, 
and for not using structured instruments for the assessment of the 
diagnosis. Further research is needed for addressing the limitations 
of this study.
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